Danette M. Pascarella

Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation

Craig W. Lindsley, William J. Ray, Michelle Pearson, 2009, Proceedings of the National Academy of Sciences.

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl-d-aspartate receptor activity

P. Jeffrey Conn, E. Scolnick, P. Mallorga, 2003, Proceedings of the National Academy of Sciences of the United States of America.

The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.

P. Mallorga, J. Hess, M. Jacobson, 2002, The Journal of pharmacology and experimental therapeutics.

Correction for d'Errico et al., Additional evidence on the use of personal ornaments in the Middle Paleolithic of North Africa

S. Doran, W. Shipe, M. Seager, 2009, Proceedings of the National Academy of Sciences.

Iterative Focused Screening with Biological Fingerprints Identifies Selective Asc-1 Inhibitors Distinct from Traditional High Throughput Screening.

Peter S. Kutchukian, Gregory T O'Donnell, Paul Zuck, 2017, ACS chemical biology.

The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine

Sarah L. Huszar, Monika Kandebo, J. Uslaner, 2008, Journal of Pharmacology and Experimental Therapeutics.

The M1 Muscarinic Receptor Allosteric Agonists AC-42 and 1-[1′-(2-Methylbenzyl)-1,4′-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one Bind to a Unique Site Distinct from the Acetylcholine Orthosteric Site

M. Jacobson, J. O'brien, Constantine Kreatsoulas, 2010, Molecular Pharmacology.

The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.

S. Venkatraman, S. Munshi, A. Pike, 2008, Bioorganic & medicinal chemistry letters.